Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-18

Clinical Trial Update: Influence of Olfaction Essential Oils on the Consumption of Benzodiazepine Receptor Agonists & Z-Drugs (BZRAs) Prescribed as " if Needed " in Psychiatric Outpatients (HECBA-PSY). [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating whether essential oils affecting olfaction influence consumption of benzodiazepine receptor agonists and Z-drugs in psychia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Etablissement Public de Santé Barthélemy Durand | Conditions: Psychiatric Disorder, Benzodiazepine Withdrawal | Phase 4 | Status: UNKNOWN